Researchers Identified Tumor Suppressor in Breast Cancer
A study found that the protein ITSN1-S works to suppress breast cancer progression through ferroptosis.
Updated on Oct. 1, 2026 in Cancer
Scientists have determined that the protein ITSN1-S functions as a tumor suppressor in breast cancer by repressing RASGRF1. This process sensitizes cancer cells to ferroptosis, a form of cell death.
Why it matters
Understanding this molecular pathway provides insight into how breast cancer cells are regulated and destroyed. This discovery highlights a potential mechanism for enhancing the effectiveness of existing treatments like cisplatin.
Researchers confirmed that nuclear ITSN1-S binds to the A/GCACACA core motif to repress RASGRF1. This mechanism subsequently downregulates GPX4, which sensitizes cells to cisplatin-induced ferroptosis.
The players
Cell Death & Disease
This is a peer-reviewed scientific journal that focuses on the mechanisms of cell death and disease development.
The details
CBP-mediated acetylation facilitates the translocation of ITSN1-S into the nucleus of breast cancer cells. Once inside, this protein binds to the RASGRF1 promoter, eventually triggering M1 macrophage polarization alongside ferroptosis.
Timeline
The research findings were published in Cell Death & Disease on October 1, 2026.
The Big Picture
This study advances the field of ferroptosis research by identifying a specific suppressor protein that dictates cell death sensitivity. By mapping this pathway, researchers have updated the understanding of how breast cancer cells evade destruction.
This discovery could eventually lead to new, more precise therapies that sensitize breast cancer tumors to chemotherapy. Patients may see future treatment protocols incorporate agents that target the ITSN1-S-RASGRF1 axis to improve clinical outcomes.
The takeaway
This study underscores the critical role of specific protein interactions in suppressing tumor growth. These insights are essential for developing future therapies that use ferroptosis to combat aggressive cancer types.
Further reading
Learn more about the latest advancements in the field of Cancer.
Source note: This article includes information reported by Nature.
